Zobrazeno 1 - 6
of 6
pro vyhledávání: '"LISA HARTON"'
Autor:
Lisa Harton, Lisa Skemp
Publikováno v:
Nursing Open, Vol 11, Iss 2, Pp n/a-n/a (2024)
Abstract Aim This study aims to describe medical‐surgical registered nurses' experiences with safety culture. Design Qualitative, Inductive descriptive. Methods Registered nurses were recruited from a Midwestern community hospital in the United Sta
Externí odkaz:
https://doaj.org/article/68a4d40857284ce6b45abb434179a2d4
Autor:
Humberto Contreras-Trujillo, Jiya Eerdeng, Samir Akre, Du Jiang, Jorge Contreras, Basia Gala, Mary C. Vergel-Rodriguez, Yeachan Lee, Aparna Jorapur, Areen Andreasian, Lisa Harton, Charles S. Bramlett, Anna Nogalska, Gang Xiao, Jae-Woong Lee, Lai N. Chan, Markus Müschen, Akil A. Merchant, Rong Lu
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
DNA barcoding is a promising technology for the simultaneous analysis of genetic and phenotypic heterogeneity. Here, the authors combine DNA barcoding and single-cell RNA-seq to study heterogeneity, progression and response to therapy in B-cell acute
Externí odkaz:
https://doaj.org/article/1cf0a0d2c96e4d41be8c44bd2d61e2d2
Autor:
Akil A. Merchant, Aparna Jorapur, Amy McManus, Ren Liu, Valery Krasnoperov, Parvesh Chaudhry, Mohan Singh, Lisa Harton, Mary Agajanian, Miriam Kim, Timothy J. Triche, Jr, Brian J. Druker, Jeffrey W. Tyner, Parkash S. Gill
Publikováno v:
Blood Advances, Vol 1, Iss 20, Pp 1635-1644 (2017)
Abstract: EPHB4, an ephrin type B receptor, is implicated in the growth of several epithelial tumors and is a promising target in cancer therapy; however, little is known about its role in hematologic malignancies. In this article, we show that EPHB4
Externí odkaz:
https://doaj.org/article/19768229a4874092be482d8c1013911e
Autor:
Lisa Harton, Lisa Skemp
Publikováno v:
Journal of nursing managementREFERENCES. 30(7)
The aim of this study is to describe safety culture as experienced by medical-surgical nurse leaders.Safety culture remains a barrier in safer patient care. Nurse leaders play an important role in creating and supporting a safety culture.We used an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bab4888395cf29536d0cda6487bb602d
https://pubmed.ncbi.nlm.nih.gov/36048854
https://pubmed.ncbi.nlm.nih.gov/36048854
Autor:
Rong Lu, HUMBERTO CONTRERAS-TRUJILLO, JIYA EERDENG, SAMIR AKRE, DU JIANG, APARNA JORAPUR, MARY VERGEL-RODRIGUEZ, AREEN ANDREASIAN, LISA HARTON, Charles Bramlett, BASIA GALA, Anna Nogalska, Lai Chan, Gang Xiao, JAE-WOONG LEE, MARKUS MÜSCHEN, AKIL MERCHANT
Cellular heterogeneity is a major cause of treatment resistance in cancer. Despite recent advances in single-cell genomic and transcriptomic sequencing, it remains difficult to relate measured molecular profiles to the cellular activities underlying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb5e2a76c2a018636433d83659af0bff
https://doi.org/10.21203/rs.3.rs-132486/v1
https://doi.org/10.21203/rs.3.rs-132486/v1
Autor:
Valery Krasnoperov, Lisa Harton, Brian J. Druker, Aparna Jorapur, Parvesh Chaudhry, Parkash S. Gill, Mohan Singh, Jeffrey W. Tyner, Akil Merchant, Ren Liu, Mary Agajanian, Amy R. McManus, Miriam Y. Kim, Timothy J. Triche
Publikováno v:
Blood Advances. 1:1635-1644
EPHB4, an ephrin type B receptor, is implicated in the growth of several epithelial tumors and is a promising target in cancer therapy; however, little is known about its role in hematologic malignancies. In this article, we show that EPHB4 is highly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c3593eb9f9c5aca1e9ac4a6a8bfca06
https://doi.org/10.1182/bloodadvances.2017005694
https://doi.org/10.1182/bloodadvances.2017005694